These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 10773428

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pharmacological characterization of the human P2Y13 receptor.
    Marteau F, Le Poul E, Communi D, Communi D, Labouret C, Savi P, Boeynaems JM, Gonzalez NS.
    Mol Pharmacol; 2003 Jul; 64(1):104-12. PubMed ID: 12815166
    [Abstract] [Full Text] [Related]

  • 24. Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations.
    Schäfer R, Reiser G.
    Br J Pharmacol; 1997 Jul; 121(5):913-22. PubMed ID: 9222547
    [Abstract] [Full Text] [Related]

  • 25. Two distinct P2 purinergic receptors, P2Y and P2U, are coupled to phospholipase C in mouse pineal gland tumor cells.
    Suh BC, Son JH, Joh TH, Kim KT.
    J Neurochem; 1997 Apr; 68(4):1622-32. PubMed ID: 9084434
    [Abstract] [Full Text] [Related]

  • 26. Evidence that 2-methylthioATP and 2-methylthioADP are both agonists at the rat hepatocyte P2Y(1) receptor.
    Dixon CJ.
    Br J Pharmacol; 2000 Jun; 130(3):664-8. PubMed ID: 10821796
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
    von Kügelgen I, Stoffel D, Starke K.
    Br J Pharmacol; 1995 May; 115(2):247-54. PubMed ID: 7670726
    [Abstract] [Full Text] [Related]

  • 30. ATP modulates intracellular Ca2+ and firing rate through a P2Y1 purinoceptor in cane toad pacemaker cells.
    Ju YK, Huang W, Jiang L, Barden JA, Allen DG.
    J Physiol; 2003 Nov 01; 552(Pt 3):777-87. PubMed ID: 12949218
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological characterization of the human P2Y11 receptor.
    Communi D, Robaye B, Boeynaems JM.
    Br J Pharmacol; 1999 Nov 01; 128(6):1199-206. PubMed ID: 10578132
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Enhancement of the response to purinergic agonists in P2Y1 transfected 1321N1 cells by antagonists suramin and PPADS.
    Brown CA, Charlton SJ, Boarder MR.
    Br J Pharmacol; 1997 Mar 01; 120(6):1049-52. PubMed ID: 9134216
    [Abstract] [Full Text] [Related]

  • 34. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB, Neary JT.
    Neuroscience; 2006 Oct 13; 142(2):411-23. PubMed ID: 16905269
    [Abstract] [Full Text] [Related]

  • 35. Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neurons.
    Gerevich Z, Müller C, Illes P.
    Eur J Pharmacol; 2005 Oct 03; 521(1-3):34-8. PubMed ID: 16181623
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Regulation of brain capillary endothelial cells by P2Y receptors coupled to Ca2+, phospholipase C and mitogen-activated protein kinase.
    Albert JL, Boyle JP, Roberts JA, Challiss RA, Gubby SE, Boarder MR.
    Br J Pharmacol; 1997 Nov 03; 122(5):935-41. PubMed ID: 9384512
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors.
    Conigrave AD, Fernando KC, Gu B, Tasevski V, Zhang W, Luttrell BM, Wiley JS.
    Eur J Pharmacol; 2001 Aug 31; 426(3):157-63. PubMed ID: 11527539
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.